ArticleScientific reports2026
Aryl hydrocarbon receptor in the kidney regulates metabolic cross-talk with the liver and gut microbiome.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Aryl hydrocarbon receptor (AHR) is central to inter-organ and inter-organismal crosstalk along the gut microbiome-liver-kidney axis. Studies in the kidney indicate this is due its regulation of transporter-mediated "remote sensing and signaling" via small molecules derived from the gut microbiome. These include gut microbiome-derived uremic toxins (e.g., indoxyl sulfate) associated with chronic kidney disease (CKD), which are transported by OAT1 and other SLC transporters. However, how kidney AHR regulates gut microbiome-liver-kidney crosstalk is largely unexplored. Here, we applied formal multi-organ metabolic reconstruction to multiomics data from the kidney of AHR knockout mouse and contextualized it with systemic metabolic changes. Consistent with the Remote Sensing and Signaling Theory, the explicit and quantitative multi-organ host and microbe network reconstruction revealed that kidney AHR regulates correlated sets of biochemical reactions at the organ, cellular, and organellar levels. In the absence of kidney AHR, there is up-regulation of polyamine related metabolism and down regulation of pathways involving organic acids (oxalate), thiamine, and amino-, methyl-, and phospho-transferases. Importantly, these AHR-dependent changes in correlated reaction sets occur not only in the kidney but also in the liver and microbiome. The normal inter-organ and inter-organismal (host-microbe) communication via these biochemical pathways between the kidney and other organs is disrupted when AHR function is lost. Thus, the incorporation of tissue and plasma metabolomics with kidney and liver transcriptomics in a biologically coherent framework provides a novel view into the metabolic relationships across the gut microbiome-liver-kidney axis. Through a concordance–discordance assessment of the transcriptome and metabolome, we were able to identify potential metabolic regulatory hubs dependent upon kidney AHR, a uremic toxin sensor and drug target. This included observed up-regulation of urea cycle enzymes with down-regulation of more distant enzymes (that are not directly involved with nitrogen handling). The results show how AHR-dependent remote sensing and signaling can involve interactions via biochemical reaction sub-networks between distinct organellar compartments of the communicating kidney and liver.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.